Abstract
In the present study, we transplanted bone marrow-derived mesenchymal stem cells into the CA3 area of the hippocampus of chronic epilepsy rats kindled by lithium chloride-pilocarpine. Immunofluorescence and western blotting revealed an increase in adenosine A1 receptor expression and a decrease in adenosine A2a receptor expression in the brain tissues of epileptic rats 3 months after transplantation. Moreover, the imbalance in the A1 adenosine receptor/A2a adenosine receptor ratio was improved. Electroencephalograms showed that frequency and amplitude of spikes in the hippocampus and frontal lobe were reduced. These results suggested that mesenchymal stem cell transplantation can reconstruct the normal function of the adenosine system in the brain and greatly improve epileptiform discharges.
Keywords: bone marrow-derived mesenchymal stem cells, chronic epilepsy, cell transplantation, reconstruction, adenosine system, electroencephalogram, immunohistochemistry
INTRODUCTION
The dysfunction of the adenosine system in chronic epilepsy is characterized by the reduction of extracellular adenosine level, change of the density of adenosine receptors and over-expression of adenosine kinase[1]. This dysfunction contributes to the pathological mechanisms underlying epilepsy and uncontrolled seizures[2,3,4]. Therefore, reconstruction of adenosine system function is important for the treatment of refractory epilepsy. Many researchers have attempted to improve adenosine system dysfunction through the application of adenosine and its analogs, adenosine receptor agonists and antagonists[5,6,7,8]. However, most of them have failed because of a lack of adenosine receptors in the brain[9]. Moreover, these compounds were shown to have side effects, such as sedation and inhibition of the cardiovascular system[10,11,12,13,14], which have restricted their clinical application. Therefore, restoration of the neural inhibitory and protective function of the adenosine system relies on reconstruction of the whole system-the ability of neurons to secrete adenosine and adenosine receptor density in astrocytes as a whole.
Stem cell transplantation has been regarded as an ideal method for such reconstruction because it is associated with minimal rejection in nervous tissue. Cell transplantation into the brain has several advantages. First, only a minimal amount of adenosine (20–50 ng/d) can inhibit epileptiform discharges[15]. Second, the concentration of adenosine secreted by transplanted cells is too low to activate the internal flow of adenosine conducted by adenosine transporters in the presynaptic membrane. Therefore, the adenosine level outside the cell membrane can be maintained at a higher level than normal[16]. Therefore, cell transplantation can provide anti-epileptic and neuroprotective effects through restoration of the adenosine system[17]. We hypothesized that transplanted stem cells could promote the functional and structural reconstruction of adenosine system, and tested this hypothesis in the present study.
RESULTS
Quantitative analysis of experimental animals
A total of 16 Wistar rats were equally and randomly divided into transplantation and model groups. An epilepsy model was induced by kindling with lithium chloride-pilocarpine. One month after kindling, bone marrow-derived mesenchymal stem cells (MSCs) were transplanted into the CA3 area of the hippocampi of rats in the transplantation group, and the same amount of PBS was injected into the same area of rats in the model group. One rat in the model group died, but it was replaced with an additional one so that eight rats were included in the final analysis.
Culture and identification of MSCs
The cultured passage 1 cells exhibited a round appearance and suspended in the culture medium with strong refraction. The cells began to adhere to the culture flask and the shape changed to become flat and spindle-shaped at 5–7 days (Figure 1). CD45 is a surface marker of lymphocytes, and does not present on MSCs[18]. By contrast, CD90 and CD105 are markers of MSCs[18]. In the present study, the cultured cells were positive for CD90 and CD105 on the surface and negative for CD45, indicating that they were in fact MSCs (Figure 2).
Figure 1.

Morphology of primary cultured bone marrow-derived mesenchymal stem cells after 6 days in culture (light microscope, × 100). Cells were fusiform-shaped and transparent.
Figure 2.

Identification of primary cultured bone marrow-derived mesenchymal stem cells after 6 days in culture by flow cytometry.
(A) Cells were negative for CD45; (B) cells were positive for CD90; (C) cells were positive for CD105.
Adenosine receptor expression in the brains of epileptic rats after MSC transplantation
Compared with the model group, the expression of the adenosine A1 receptor in the temporal lobe and hippocampus was up-regulated (P < 0.05, P < 0.01) and expression of the adenosine A2a receptor in the thalamus was down-regulated (P < 0.05) as detected by immunofluorescence and western blot methods; moreover, the imbalance in the adenosine receptor A1/A2a ratio was improved at 3 months after transplantation (Figures 3, 4 and Table 1).
Figure 3.

Expression of adenosine A1 and A2a receptors (A1R, A2aR) in the brains of epileptic rats (immunohistochemical staining, × 400). A1R expression in the temporal lobe and hippocampus increased and A2aR expression in the thalamus decreased at 3 months after transplantation. Cells that showed green or red fluorescence on the membrane were defined as positive cells.
Figure 4.

Expression of adenosine A1 receptor and A2a receptor in the brains of epileptic rats at 3 months after cell transplantation (western blot). The level of A1 receptor increased in the temporal lobe and hippocampus and that of A2a receptor decreased in the thalamus 3 months after transplantation.
Table 1.
Numbers of adenosine A1 receptor- and A2a receptor-positive cells as observed by immunohistochemistry at 3 months after transplantation (cells/400-fold field of view)

Influence of MSC transplantation on epileptic discharges
Before transplantation, the spike discharge frequency was 19.65 ± 2.18 per 29 cm and the amplitude was 297.43 ± 25.37 mV in the cortex and hippocampus. After MSC transplantation, the spike discharge frequency was reduced to 7.48 ± 0.91 per 29 cm (P < 0.01), and the amplitude reduced to 86.27 ± 7.72 mV (P < 0.01; Figure 5).
Figure 5.

Alteration of electroencephalograms in epileptic rats. The amplitude and count of spike discharges were reduced. Lines 1 and 2 present results in the cortex and hippocampus in model rats, respectively (150 mV/cm). Upper: before transplantation; lower: 3 months after transplantation (1 mm = 25 V).
However, the count and amplitude of discharges in the model group remained unchanged after transplantation (P > 0.05).
DISCUSSION
Transplantation of MSCs has been shown to increase the amount of adenosine in the hippocampus of rats[19]. In the present study, at 3 months after transplantation, A1 adenosine receptor expression in the hippocampus and temporal lobe was significantly increased in epileptic rats, while A2a adenosine receptor expression in the thalamus was significantly decreased, indicating that MSC transplantation can improve the imbalance in adenosine receptors in the brain. Boison et al[20,21] transplanted embryonic stem cells into epileptic animals and concluded that the transplantation reduced both seizure frequency and electroencephalogram (EEG) discharges, consistent with the present results. Moreover, these authors indicated that transplanted stem cells can secrete adenosine, differentiate into functional neurons and connect with other neurological function cells. This ability of the cells makes them promising for use in anti-epileptic and neuroprotective therapies.
Because of the long-term stimulation of adenosine receptors in the brain by high levels of adenosine caused by seizures, the sensibility of these receptors gradually reduces, their expression changes and their density is disturbed[22,23]. That is, adenosine and its analogues can exaggerate the dysfunction of the adenosine system and seizures. However, does adenosine secreted by transplanted cells exaggerate adenosine system dysfunction? Gomes et al[17] suggested it did not, because (1) the improvement of seizure frequency was maintained for at least 8 weeks; (2) seizures in animals became more serious after application of selective A1 receptor antagonists, indicating that the inhibitory function mediated by adenosine A1 receptor is important in seizure control; and (3) with prolonged time, the transplanted cells gradually died and the secretion function gradually decreased (this was associated with an obvious increase in the frequency of seizures). All these findings show that adenosine secreted by transplanted cells can have an anti-epileptic function. In the present study, expression levels of both of the high-affinity adenosine receptors examined were improved 3 months after transplantation.
In summary, in the present study, we attempted to restore normal function to the adenosine system in the brain through the transplantation of MSCs. The amplitude and frequency of spike waves were significantly reduced and the imbalance in the expression of adenosine receptors was improved.
MATERIALS AND METHODS
Design
A randomized, controlled, animal study.
Time and setting
The experiment was performed in the Neuroscience Laboratory of Tongji Hospital affiliated to Tongji Medical College, Huazhong University of Science and Technology, China from April 2007 to May 2008.
Materials
Specific pathogen-free, male Wistar rats, aged 10–12 weeks, weighing 220–250 g, were purchased from the Animal Center of Tongji Medical College, Huazhong University of Science and Technology (license No. SYXK (E) 2004-0028). The animals were housed in groups of five under a continuous 12-hour dark/light cycle and allowed free access to water and food. All procedures were performed in accordance with the Guidance Suggestions for the Care and Use of Laboratory Animals, formulated by the Ministry of Science and Technology of China[24].
Methods
Culture and identification of MSCs
Wistar rats were sacrificed after anesthesia by diethyl ether and immersed in 75% alcohol for 8 minutes. The intact femur and tibia were separated, washed in iced phosphate buffered saline solution, and the muscle and bone membrane were removed. The ends of the femur and tibia were cut, and the marrow cavity was washed with phosphate buffered saline three times. The flushed fluid was centrifuged at 1 000 r/min for 10 minutes. The cells were suspended in complete medium (80% low-glucose Dulbecco's modified Eagle's medium/18% fetal calf serum/1% penicillin-streptomycin/1% glutamate/epidermal growth factor), plated in culture flasks at a density of 5 × 106/mL, and incubated in a saturated humidity incubator with 5% CO2 at 37°C[25]. MSCs were identified by detecting the surface markers CD45, CD90 and CD105[18] using flow cytometry (BD, Franklin Cakes, NY, USA).
Preparation of epileptic model
The model was established according to previously described methods[26]. Briefly, animals were intraperitoneally injected with pilocarpine (50 mg/kg; Sigma, St. Louis, MO, USA) 18–24 hours after the intraperitoneal injection of lithium chloride (3 mmol/kg; Sigma). A majority of animals developed a limbic status epilepticus that was terminated by injection of diazepam (0.5–2.5 mg; Shihongkemao Co., Ltd., Wuhan, China) 40 minutes after onset. Seizures that reached grade IV to V[27] were defined as fully kindled.
MSC transplantation into the hippocampus
Cultured and identified MSCs were trypsinized, suspended in PBS and transplanted at a density of 2 × 106/mL. Rats that had been kindled for 1 month were anesthetized by intraperitoneal injection of 6% chloral hydrate (0.5 mL/100 g). The rats were placed on a stereotaxic instrument (Morishige, Sr-5r, Japan) and the bregma and posterior fontanelle were maintained on the same line. The bregma was exposed and the right hippocampus was located (3.8 mm posterior to the bregma, 3.2 mm from the midline, 3.5 mm deep)[28]. The skull was drilled with the pinhead of the injector until the dura mater was seen. A 2-μL cell suspension was transplanted at a speed of 0.2 μL/min for a total of 10 minutes using a microinjector (Micro-syringe, Chuangxintongheng Science and Technology Co., Ltd., Beijing). The needle was maintained for 10–15 minutes and slowly removed. The transplantation hole was closed with bone wax.
Immunofluorescence detection for adenosine receptor expression after transplantation
The rats were anesthetized with diethyl ether and sacrificed 3 months after transplantation. The brains were harvested immediately. Frozen sections of temporal lobe and thalamus (10 mm thick) were prepared to detect the expression of adenosine receptors by immunofluorescence. The primary antibodies used were rabbit anti-rat A1 receptor monoclonal antibody (1: 100; AbCam, Cambridge, UK) and mouse anti-rat A2a receptor monoclonal antibody (1: 100; Upstate, New York, NY, USA). Secondary antibodies were Cy3-conjugated goat anti-mouse polyclonal antibody (1: 300; Zhongshan Goldenbridge Biotechnology, Beijing, China) and fluorescein isothiocyanate-conjugated goat anti-rabbit polyclonal antibody (1: 300; Zhongshan Goldenbridge Biotechnology). Sections were incubated with primary antibodies for 2 hours and with secondary antibodies for 45 minutes. Cells that showed green or red fluorescence on the membrane were defined as positive cells. Two sections from each animal were selected and the number of positive cells in ten high-power fields of view (× 400) from one section was measured (Olympus, Tokyo, Japan).
Western blot detection for adenosine receptor expression after transplantation
Protein was extracted from temporal lobe and thalamus. After dilution in sodium dodecyl sulfate polyacrylamide gel electrophoresis sample buffer, samples were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis between 120 V and 80 V, electrotransferred to polyvinylidene difluoride membranes at 200 mA for 60 minutes. Membranes were blocked at room temperature for 2 hours and incubated overnight at 4°C with antibodies against the rabbit anti-rat A1 receptor IgG (1: 1 000; AbCam) and mouse anti-rat A2a receptor IgG (1: 100; Upstate). After three washes in Tris-buffered saline containing Tween-20, each for 5 minutes, membranes were incubated with goat anti-rabbit/mouse lgG (1: 100; Boster, Wuhan, China) at room temperature for 60 minutes. After three washes in Tris-buffered saline containing Tween-20, each for 10 minutes, membranes were stained with diaminobenzidine (Zhongshan Goldenbridge Biotechnology). β-actin was used as an internal reference. Band intensities were analyzed using Image Quart Software (Gene genius, Syngene, Cambridge, UK). Relative density was calculated by dividing the intensity of adenosine receptor bands by that of β-actin bands. The intensity of each protein band was detected in triplicate.
EEG changes in rats after MSC transplantation
EEG recordings were performed before and 3 months after transplantation using an animal electroencephalograph (NT92-SH16, GM, Shanghai, China). Two electrodes were placed separately in the frontal lobe (2.0 mm anterior to the bregma, 2.0 mm from the midline and 0.5 mm deep) and in the CA3 of the hippocampus (2.0 mm posterior to the bregma, 3.2 mm from the midline and 3.5 mm deep). The other two were a groundwire and reference electrode. In the recorder, 2 mm amounted to 50 V and the running speed of paper was 15 mm/s. Recordings continued for 15 minutes. The average spike wave frequency and the amplitude of spike discharges were calculated. All the data were averaged.
Statistical analysis
All data are expressed as mean ± SD and analyzed using SPSS 11.5 software (SPSS, Chicago, IL, USA). Comparisons of data between two groups were performed by one-way analysis of variance. A value of P < 0.05 was considered statistically different.
Footnotes
Conflicts of interest: None declared.
Ethical approval: The experiment was approved by the Animal Ethics Committee of Tongji Hospital affiliated to Tongji Medical College, China.
(Edited by Wang Z, Shi J/Su LL/Song LP)
REFERENCES
- [1].Boison D. The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol. 2008;84(3):249–262. doi: 10.1016/j.pneurobio.2007.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Boison D. Adenosine dysfunction and adenosine kinase in epileptogenesis. Open Neurosci J. 2010;4:93–101. doi: 10.2174/1874082001004020093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Boison D. Adenosine as a modulator of brain activity. Drug News Perspect. 2007;20(10):607–611. doi: 10.1358/dnp.2007.20.10.1181353. [DOI] [PubMed] [Google Scholar]
- [4].Fedele DE, Gouder N, Güttinger M, et al. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain. 2005;128(Pt 10):2383–2395. doi: 10.1093/brain/awh555. [DOI] [PubMed] [Google Scholar]
- [5].Fukuda M, Suzuki Y, Hino H, et al. Activation of central adenosine A(2A) receptors lowers the seizure threshold of hyperthermia- induced seizure in childhood rats. Seizure. 2011;20(2):156–159. doi: 10.1016/j.seizure.2010.11.012. [DOI] [PubMed] [Google Scholar]
- [6].Mareš P. Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors. J Neural Transm. 2010;117(11):1269–1277. doi: 10.1007/s00702-010-0465-9. [DOI] [PubMed] [Google Scholar]
- [7].Van Dycke A, Raedt R, Dauwe I, et al. Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures. Epilepsia. 2010;51(9):1721–1728. doi: 10.1111/j.1528-1167.2010.02700.x. [DOI] [PubMed] [Google Scholar]
- [8].Dale N, Frenguelli BG. Release of adenosine and ATP during ischemia and epilepsy. Curr Neuropharmacol. 2009;7(3):160–179. doi: 10.2174/157015909789152146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Fuxe K, Ferré S, Genedani S, et al. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav. 2007;92(1-2):210–217. doi: 10.1016/j.physbeh.2007.05.034. [DOI] [PubMed] [Google Scholar]
- [10].Boison D, Stewart KA. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol. 2009;78(12):1428–1437. doi: 10.1016/j.bcp.2009.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Giraldez L, Girardi E. Effects of an adenosine analogue administration on the striatal NMDA receptors in an experimental model of epilepsy. Neurochem Int. 2000;36(3):243–247. doi: 10.1016/s0197-0186(99)00116-3. [DOI] [PubMed] [Google Scholar]
- [12].Moro S, Gao ZG, Jacobson KA, et al. Progress in the pursuit of therapeutic adenosine receptor antagonists. Med Res Rev. 2006;26(2):131–159. doi: 10.1002/med.20048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Sebastião AM, Ribeiro JA. Adenosine receptors and the central nervous system. Handb Exp Pharmacol. 2009;193:471–534. doi: 10.1007/978-3-540-89615-9_16. [DOI] [PubMed] [Google Scholar]
- [14].Boison D, Scheurer L, Tseng JL, et al. Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp Neurol. 1999;160(1):164–174. doi: 10.1006/exnr.1999.7209. [DOI] [PubMed] [Google Scholar]
- [15].Dunwiddie TV. Adenosine and suppression of seizures. Adv Neurol. 1999;79:1001–1010. [PubMed] [Google Scholar]
- [16].Güttinger M, Padrun V, Pralong WF, et al. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol. 2005;193(1):53–64. doi: 10.1016/j.expneurol.2004.12.012. [DOI] [PubMed] [Google Scholar]
- [17].Gomes CV, Kaster MP, Tomé AR, et al. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta. 2011;1808(5):1380–1399. doi: 10.1016/j.bbamem.2010.12.001. [DOI] [PubMed] [Google Scholar]
- [18].Dvorakova J, Hruba A, Velebny V, et al. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets. Cell Biol Int. 2008;32(9):1116–1125. doi: 10.1016/j.cellbi.2008.04.024. [DOI] [PubMed] [Google Scholar]
- [19].Ren G, Li T, Lan JQ, et al. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol. 2007;208(1):26–37. doi: 10.1016/j.expneurol.2007.07.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Boison D, Huber A, Padrun V, et al. Seizure suppression by adenosine-releasing cells is independent of seizure frequency. Epilepsia. 2002;43(8):788–796. doi: 10.1046/j.1528-1157.2002.33001.x. [DOI] [PubMed] [Google Scholar]
- [21].Boison D. Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics. 2009;6(2):278–283. doi: 10.1016/j.nurt.2008.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Kang HC, Hu Q, Liu XY, et al. The dynamic changes of adenosine receptors imbalance during kindling by lithium chloride-pilocarpine. Zhonghua Shenjing Ke Zazhi. 2009;42(3):185–189. [Google Scholar]
- [23].Rebola N, Coelho JE, Costenla AR, et al. Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur J Neurosci. 2003;18(4):820–828. doi: 10.1046/j.1460-9568.2003.02815.x. [DOI] [PubMed] [Google Scholar]
- [24].The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30 [Google Scholar]
- [25].Hu Q, Kang HC, Liu XY, et al. Migration and differentiation of mesenchymai stem cells labeled with enhanced green fluorescent protein in the Parkinson's disease rat brain. Huazhong Keji Daxue Xuebao: Yixue Ban. 2009;38(2):181–184. [Google Scholar]
- [26].Su M, Tong XX. Astrocytic gap junction in the hippocampus of rats with lithium pilocarpine-induced epilepsy. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(12):2738–2741. [PubMed] [Google Scholar]
- [27].Pohle W, Becker A, Grecksch G, et al. Piracetam prevents pentylenetetrazol kindling-induced neuronal loss and learning deficits. Seizure. 1997;6(6):467–474. doi: 10.1016/s1059-1311(97)80022-2. [DOI] [PubMed] [Google Scholar]
- [28].Mochizuki N, Takagi N, Kurokawa K, et al. Injection of neural progenitor cells improved learning and memory dysfunction after cerebral ischemia. Exp Neurol. 2008;211(1):194–202. doi: 10.1016/j.expneurol.2008.01.027. [DOI] [PubMed] [Google Scholar]
